ClinicalTrials.gov
public full text
Public Domain
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia
Patients with diagnosis of HPIN were enrolled. Patients were randomized into two groups: dutasteride treatment group and watchful waiting strategy group. According to the study protocol the subjects would undergo 10 core biopsies after 6, 12, 24, and 36 months after randomization. There are assessed the rate of prostate cancer at repeated transrectal ultrasound guided biopsies and the effect of 5 alfa reductase inhibitor (dutasteride) on prevention of prostate cancer development for patients with high grade intraepithelial neoplasia (HPIN).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer#1183056
- Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer#835758
- Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer#1321383
- Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer#877374
- Digoxin for Recurrent Prostate Cancer#1259153
Record · ID 1261311
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive